SAN FRANCISCO, Oct. 31, 2024/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2024 on Thursday, November 7, 2024, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/. The web broadcast of the conference call will be available for replay through December 7, 2024.

To access the conference call, please pre-register at Nektar Earnings Call Registration. All registrants will receive dial-in information and a PIN allowing them to access the live call.

About Nektar Therapeutics
NektarTherapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmuneand chronic inflammatory diseases. Nektar'slead product candidate, rezpegaldesleukin(REZPEG, or NKTR-358), is a novel, first-in-class regulatory Tcell stimulator being evaluated in two Phase 2b clinical trials, one in atopicdermatitis and one in alopecia areata. Our pipeline also includes a preclinical candidate NKTR-0165, which is a bivalent tumor necrosis factor receptor type II agonistantibody. Nektar, together with various partners, is also evaluating NKTR-255, an investigational IL-15 receptor agonistdesigned to boost the immune system's natural ability to fight cancer, in several ongoing clinical trials. Nektaris headquartered in San Francisco, California. For further information, visit www.nektar.comand follow us on LinkedIn.

Contacts:

For Investors:
Vivian Wuof NektarTherapeutics
(628) 895-0661

For Media:
Madelin Hawtin
LifeSciCommunications
603-714-2638
mhawtin@lifescicomms.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-third-quarter-2024-on-thursday-november-7-2024-after-close-of-us-based-financial-markets-302293320.html

SOURCE Nektar Therapeutics